- Home
- ISPO vs CLNN Comparison
ISPO vs CLNN Comparison
Compare ISPO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- CLNN
- Stock Information
- Founded
- ISPO 2010
- CLNN 2012
- Country
- ISPO United States
- CLNN United States
- Employees
- ISPO N/A
- CLNN N/A
- Industry
- ISPO Blank Checks
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- CLNN Health Care
- Exchange
- ISPO Nasdaq
- CLNN Nasdaq
- Market Cap
- ISPO 39.0M
- CLNN 43.0M
- IPO Year
- ISPO N/A
- CLNN N/A
- Fundamental
- Price
- ISPO $3.59
- CLNN $4.34
- Analyst Decision
- ISPO Buy
- CLNN Strong Buy
- Analyst Count
- ISPO 2
- CLNN 4
- Target Price
- ISPO $10.50
- CLNN $55.25
- AVG Volume (30 Days)
- ISPO 37.6K
- CLNN 121.1K
- Earning Date
- ISPO 10-28-2024
- CLNN 11-13-2024
- Dividend Yield
- ISPO N/A
- CLNN N/A
- EPS Growth
- ISPO N/A
- CLNN N/A
- EPS
- ISPO N/A
- CLNN N/A
- Revenue
- ISPO $287,451,000.00
- CLNN $421,000.00
- Revenue This Year
- ISPO N/A
- CLNN N/A
- Revenue Next Year
- ISPO N/A
- CLNN N/A
- P/E Ratio
- ISPO N/A
- CLNN N/A
- Revenue Growth
- ISPO N/A
- CLNN N/A
- 52 Week Low
- ISPO $3.11
- CLNN $3.82
- 52 Week High
- ISPO $9.31
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- ISPO 50.23
- CLNN 44.40
- Support Level
- ISPO $3.21
- CLNN $4.22
- Resistance Level
- ISPO $3.68
- CLNN $5.47
- Average True Range (ATR)
- ISPO 0.25
- CLNN 0.45
- MACD
- ISPO -0.01
- CLNN 0.06
- Stochastic Oscillator
- ISPO 48.72
- CLNN 30.57
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).